JP2021512954A5 - - Google Patents

Info

Publication number
JP2021512954A5
JP2021512954A5 JP2020564046A JP2020564046A JP2021512954A5 JP 2021512954 A5 JP2021512954 A5 JP 2021512954A5 JP 2020564046 A JP2020564046 A JP 2020564046A JP 2020564046 A JP2020564046 A JP 2020564046A JP 2021512954 A5 JP2021512954 A5 JP 2021512954A5
Authority
JP
Japan
Prior art keywords
methyl
trifluoromethyl
phenyl
quinazoline
pyrazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020564046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512954A (ja
JP7382348B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/016705 external-priority patent/WO2019156987A1/en
Publication of JP2021512954A publication Critical patent/JP2021512954A/ja
Publication of JP2021512954A5 publication Critical patent/JP2021512954A5/ja
Application granted granted Critical
Publication of JP7382348B2 publication Critical patent/JP7382348B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020564046A 2018-02-06 2019-02-05 AhRモジュレータ Active JP7382348B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862626739P 2018-02-06 2018-02-06
US62/626,739 2018-02-06
US201962793260P 2019-01-16 2019-01-16
US62/793,260 2019-01-16
PCT/US2019/016705 WO2019156987A1 (en) 2018-02-06 2019-02-05 AhR MODULATORS

Publications (3)

Publication Number Publication Date
JP2021512954A JP2021512954A (ja) 2021-05-20
JP2021512954A5 true JP2021512954A5 (cg-RX-API-DMAC7.html) 2022-02-15
JP7382348B2 JP7382348B2 (ja) 2023-11-16

Family

ID=65494575

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020564046A Active JP7382348B2 (ja) 2018-02-06 2019-02-05 AhRモジュレータ

Country Status (10)

Country Link
US (3) US10815250B2 (cg-RX-API-DMAC7.html)
EP (2) EP4219495A1 (cg-RX-API-DMAC7.html)
JP (1) JP7382348B2 (cg-RX-API-DMAC7.html)
CN (1) CN111683950B (cg-RX-API-DMAC7.html)
CA (1) CA3090150A1 (cg-RX-API-DMAC7.html)
DK (1) DK3749669T6 (cg-RX-API-DMAC7.html)
ES (1) ES2946632T7 (cg-RX-API-DMAC7.html)
FI (1) FI3749669T6 (cg-RX-API-DMAC7.html)
TW (1) TWI840343B (cg-RX-API-DMAC7.html)
WO (1) WO2019156987A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019018562A1 (en) * 2017-07-19 2019-01-24 Ideaya Biosciences, Inc. AMIDO COMPOUND AS MODULATORS OF AHR
EP4219495A1 (en) 2018-02-06 2023-08-02 Ideaya Biosciences, Inc. Ahr modulators
KR20260057216A (ko) * 2019-11-22 2026-04-27 세일 바이오메디슨스, 인크. Ahr 길항제로서의 피리도피리미디논 유도체
MX2022012739A (es) * 2020-04-17 2022-11-07 Dong A St Co Ltd Derivados de piridopirimidinona y su uso como moduladores del receptor de hidrocarburos de arilo.
WO2021236717A1 (en) 2020-05-20 2021-11-25 Senda Biosciences, Inc. Fused imidazole derivatives as ahr antagonists
CN114181212B (zh) * 2020-09-15 2023-06-06 山东轩竹医药科技有限公司 哒嗪酮类AhR抑制剂
WO2022081649A1 (en) * 2020-10-13 2022-04-21 Senda Biosciences, Inc. Biomarkers related to immune checkpoint inhibitor therapy and methods of using the same
WO2023020512A1 (zh) * 2021-08-16 2023-02-23 成都奥睿药业有限公司 取代的吡啶类似物、其制备方法及作为ahr调节剂的用途
CN118076613A (zh) * 2021-09-02 2024-05-24 捷豹治疗有限公司 可用于调节AhR信号传导的化合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20010795A2 (en) 1999-04-28 2003-02-28 Aventis Pharma Gmbh Di-aryl acid derivatives as ppar receptor ligands
CA2454080A1 (en) 2001-08-13 2003-02-27 Robert Edward Detlefsen Ultraviolet light absorbers
US7098222B2 (en) 2004-05-12 2006-08-29 Abbott Laboratories Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
US20050256118A1 (en) 2004-05-12 2005-11-17 Altenbach Robert J Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
CR9465A (es) 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente
WO2007016525A2 (en) 2005-07-29 2007-02-08 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
CA2700988A1 (en) 2006-09-27 2008-05-08 Surface Logix, Inc. Rho kinase inhibitors
UA106037C2 (uk) 2008-02-04 2014-07-25 Мерк'Юрі Терап'Ютікс, Інк. Модулятори ampk (амф-активованої протеїнкінази)
AU2009243006B2 (en) 2008-05-01 2013-03-21 Sirtris Pharmaceuticals, Inc. Quinolines and related analogs as sirtuin modulators
CN102105464A (zh) 2008-05-27 2011-06-22 德克萨斯大学系统董事会 Wnt蛋白信号转导抑制剂
MX2011009568A (es) 2009-03-09 2011-12-06 Surface Logix Inc Inhibidores de la rho cinasa.
WO2010148350A1 (en) * 2009-06-18 2010-12-23 Cornell University Photoproducts of tryptophan, their synthesis and uses thereof
US10314810B2 (en) * 2010-07-27 2019-06-11 Trustees Of Boston University Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics
KR20130065728A (ko) * 2010-10-14 2013-06-19 임뮤나르 에이비 Ahr 활성화제로서의 1,2-디히드로-4-히드록시-2-옥소-퀴놀린-3-카르복사닐리드
WO2012064973A2 (en) 2010-11-10 2012-05-18 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
USRE47009E1 (en) 2011-02-01 2018-08-28 The Children's Hospital Of Philadelphia HDAC inhibitors and therapeutic methods using the same
WO2013086436A1 (en) 2011-12-08 2013-06-13 Fred Hutchinson Cancer Research Center Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
US11427600B2 (en) * 2014-06-27 2022-08-30 Nogra Pharma Limited Aryl receptor modulators and methods of making and using the same
JP6980534B2 (ja) 2015-06-25 2021-12-15 ザ チルドレンズ メディカル センター コーポレーション 造血幹細胞の増大、富化、および維持に関する方法および組成物
WO2017184547A1 (en) 2016-04-18 2017-10-26 New York University Quinoline compounds as modulators of rage activity and uses thereof
TWI674260B (zh) 2017-02-01 2019-10-11 德商菲尼克斯製藥股份有限公司 芳基烴受體(AhR)調節劑化合物
TWI752155B (zh) 2017-02-01 2022-01-11 德商菲尼克斯製藥股份有限公司 芳香烴受體(AhR)調節劑化合物
TW201835070A (zh) 2017-02-21 2018-10-01 德商菲尼克斯製藥股份有限公司 芳香烴受體(AhR)調節劑化合物
MX2019012431A (es) 2017-04-21 2020-08-03 Ikena Oncology Inc Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
WO2019018562A1 (en) 2017-07-19 2019-01-24 Ideaya Biosciences, Inc. AMIDO COMPOUND AS MODULATORS OF AHR
EP4219495A1 (en) 2018-02-06 2023-08-02 Ideaya Biosciences, Inc. Ahr modulators
US20210254006A1 (en) 2018-06-06 2021-08-19 Ideaya Biosciences, Inc. Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds

Similar Documents

Publication Publication Date Title
JP2016504363A5 (cg-RX-API-DMAC7.html)
RU2015131148A (ru) СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1, 2, 4]ТРИАЗОЛО[1, 5c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ А2А АНТАГОНИСТОВ
JP2021503004A5 (cg-RX-API-DMAC7.html)
CN117651700A (zh) 2-氨基苯并噻唑化合物及使用方法
JP2021528467A5 (cg-RX-API-DMAC7.html)
JP2023549055A5 (cg-RX-API-DMAC7.html)
RU2012136907A (ru) Модуляторы гамма-секретазы
BR112021001292A2 (pt) compostos heterobicíclicos para inibir a atividade de shp2
HRP20120105T1 (hr) Aminoheterociklički spojevi
JP2024517693A5 (cg-RX-API-DMAC7.html)
JP2021528466A5 (cg-RX-API-DMAC7.html)
JP2021519291A5 (cg-RX-API-DMAC7.html)
JP2015511245A5 (cg-RX-API-DMAC7.html)
RU2018112230A (ru) Бициклические соединения в качестве ингибиторов atx
JP2021501806A5 (cg-RX-API-DMAC7.html)
RU2016111675A (ru) Соединения биарилацетамида и способы их применения
JP2012515205A5 (cg-RX-API-DMAC7.html)
JP2014506929A5 (cg-RX-API-DMAC7.html)
FI3814357T3 (fi) Heterosykliset ja heteroaryliyhdisteet huntingtonin taudin hoitoon
JP2020522570A5 (cg-RX-API-DMAC7.html)
JP2011500774A5 (cg-RX-API-DMAC7.html)
JP2022502424A5 (cg-RX-API-DMAC7.html)
KR920019794A (ko) 융합 헤테로시클릭 화합물, 그의 제조방법 및 용도
NZ586579A (en) Fused heterocyclic derivatives and methods of use as c-met inhibitors
US20170145034A1 (en) Alkynyl alcohols and methods of use